Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    16478899 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated The Effect of Rimonabant on Energy Expenditure, Fat Metabolism and Body Composition
Condition: Obesity
Interventions: Drug: rimonabant;   Behavioral: Dietary intervention
2 Completed Obese Patients With or Without Comorbidities (RIO-North America)
Conditions: Obesity;   Weight Loss
Intervention: Drug: Rimonabant (SR141716)

Indicates status has not been verified in more than two years